Fate Therapeutics, Inc. (FATE): Price and Financial Metrics
FATE Price/Volume Stats
| Current price | $2.22 | 52-week high | $8.83 |
| Prev. close | $2.18 | 52-week low | $1.96 |
| Day low | $2.03 | Volume | 2,373,500 |
| Day high | $2.35 | Avg. volume | 2,284,083 |
| 50-day MA | $3.02 | Dividend yield | N/A |
| 200-day MA | $4.42 | Market Cap | 252.84M |
FATE Stock Price Chart Interactive Chart >
Fate Therapeutics, Inc. (FATE) Company Bio
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops programmed cellular immunotherapies for cancer and immune disorders in the United States. The company was founded in 2007 and is based in San Diego, California.
FATE Price Returns
| 1-mo | -30.41% |
| 3-mo | -42.19% |
| 6-mo | -36.93% |
| 1-year | -7.11% |
| 3-year | -95.77% |
| 5-year | -84.57% |
| YTD | -40.64% |
| 2023 | -62.93% |
| 2022 | -82.76% |
| 2021 | -35.65% |
| 2020 | 364.64% |
| 2019 | 52.53% |
Continue Researching FATE
Here are a few links from around the web to help you further your research on Fate Therapeutics Inc's stock as an investment opportunity:Fate Therapeutics Inc (FATE) Stock Price | Nasdaq
Fate Therapeutics Inc (FATE) Stock Quote, History and News - Yahoo Finance
Fate Therapeutics Inc (FATE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...